|
|
| What Happens If The National Cancer Institute Loses Funding? | Guest Column | By Louis Johnson | The National Cancer Institute is operating under a continuing resolution that maintains funding at the FY 2024 level of $7.22 billion. But when adjusted for inflation, it effectively reduces the real value of research dollars. So what are the consequences? |
|
|
| Advancing Development Of New Oncology Therapies | Webinar | Veristat, Inc. | Learn how the FDA's Project FrontRunner expedites cancer drug approval for early advanced metastatic cancer, emphasizing efficacy and safety in earlier clinical settings. |
|
|
| 2024 Safety And Regulatory Compliance Trends And Predictions | White Paper | IQVIA Safety & Regulatory Compliance | The introduction of artificial intelligence and machine learning into pharmacovigilance, safety, and regulatory workflows stands to have a major impact on process efficiency and employee workloads. |
|
|
|
| 8 Critical Questions To Ask Your IRB | Article | BRANY | This article outlines eight essential questions to ask a potential IRB partner to assess their ability to help you navigate complex regulatory requirements while avoiding delays. |
|
|
|
|
|
|
|
|
| SMART First Human Dose (FHD) | Brochure | PCI Pharma Services | A CDMO with the right team of experts can aid drug development, regulatory compliance, and clinical trial supply, accelerating timelines to first human dose clinical trials and the path to market. |
|
|
| Your Partners In Drug Development And Safety | Brochure | Ergomed Clinical Research | How can Ergomed use its oncology expertise, global reach, and access to patients with rare and ultra-rare diseases can help your organization achieve efficient, high-quality clinical trial execution? |
|
|
| Drug-Drug Interaction Clinical Trials | Brochure | Altasciences | We specialize in DDI studies, including stand-alone and 'cocktail' designs, assessing multiple CYP enzymes or transporters in single studies, from simple crossovers to complex adaptive trials. |
|
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Thursday edition of the Clinical Leader newsletter, focusing on Outsourcing Models and Regulatory & Compliance. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
Connect With Clinical Leader: |
|
|
|